Auriga Reiterates a 'Buy' on Steven Madden (SHOO); Q4 Preview
SHOO Hot Sheet
Rating Summary:4 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 82
Auriga reiterates a 'Buy' on Steven Madden (NASDAQ: SHOO) price target of $45.00.
Auriga analyst says, "We are maintaining our Q4 EPS estimate of $0.54 for SHOO ahead of Q4. Checks pointed to a strong fall/holiday season with an on-trend boot offering. We expect SHOO to guide 2012 in a range at or above our $2.71 EPS estimate, representing 21% earnings growth versus 2011. We expect that SHOO should continue to generate strong revenue and earnings from its on-trend footwear and accessories offerings. We believe SHOO remains aggressive with its pursuit of acquisitions and another announcement is possible in the next several quarters."
For an analyst ratings summary and ratings history on Steven Madden click here. For more ratings news on Steven Madden click here.
Shares of Steven Madden closed at $40.05 yesterday, with a 52 week range of $27.80-$58.01.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Auriga analyst says, "We are maintaining our Q4 EPS estimate of $0.54 for SHOO ahead of Q4. Checks pointed to a strong fall/holiday season with an on-trend boot offering. We expect SHOO to guide 2012 in a range at or above our $2.71 EPS estimate, representing 21% earnings growth versus 2011. We expect that SHOO should continue to generate strong revenue and earnings from its on-trend footwear and accessories offerings. We believe SHOO remains aggressive with its pursuit of acquisitions and another announcement is possible in the next several quarters."
For an analyst ratings summary and ratings history on Steven Madden click here. For more ratings news on Steven Madden click here.
Shares of Steven Madden closed at $40.05 yesterday, with a 52 week range of $27.80-$58.01.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Barclays Maintains an 'Equalweight' on Apollo Commercial Real Estate Finance (ARI); Effectively Using Capital, But Shares Trading In-line Vs. Peers
- Barclays Raises PT and Estimates on Regency Centers (REG); Operations On Track
- Oppenheimer Reiterates an 'Outperform' on MakeMyTrip (MMYT); Updating Estimates Ahead of March Qtr
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Auriga, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
